Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis

Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). The aim of this study was to explore the safety and efficacy of open-label tofacitinib following blinded treatment ...

Source: Arthritis Research and Therapy - June 23, 2016 Category: Rheumatology Authors: Mark C. Genovese, Ronald F. van Vollenhoven, Bethanie Wilkinson, Lisy Wang, Samuel H. Zwillich, David Gruben, Pinaki Biswas, Richard Riese, Liza Takiya and Thomas V. Jones Source Type: research